While recent studies have confirmed SIRT1’s role in the pathogenesis of peritoneal fibrosis [22,23,24], it remains unclear whether SIRT1 could serve as a clinically useful biomarker of peritoneal membrane function measurable in serum. This evidence concerns the gene SIRT1 and Peritoneal Fibrosis.